Literature DB >> 1175295

An estimate of the turnover rate of bone-derived plasma alkaline phosphatase in Paget's disease.

R J Walton, C J Preston, R G Russell, J A Kanis.   

Abstract

A through-knee amputation for suspected osteogenic sarcoma was performed on a patient with Paget's disease of the tibia. Plasma alkaline phosphatase (AP) activity fell to normal values, apparently as a single exponential function of time, with a half-life of 1.7 days. The daily turnover of bone-derived plasma AP was estimated to be approximately 200 I.U. from the Pagetic tibia and 20 I.U. from the rest of the skeleton.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1175295     DOI: 10.1016/0009-8981(75)90167-9

Source DB:  PubMed          Journal:  Clin Chim Acta        ISSN: 0009-8981            Impact factor:   3.786


  8 in total

Review 1.  Selective drug delivery to bone using acidic oligopeptides.

Authors:  Junko Ishizaki; Yoshihiro Waki; Tatsuo Takahashi-Nishioka; Koichi Yokogawa; Ken-Ichi Miyamoto
Journal:  J Bone Miner Metab       Date:  2008-11-19       Impact factor: 2.626

2.  The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.

Authors:  J A Kanis; M Earnshaw; G Heynen; R G Russell; C G Woods
Journal:  Calcif Tissue Res       Date:  1977-05

3.  Efficacy of wheat germ lectin-precipitated alkaline phosphatase in serum as an estimator of bone mineralization rate: comparison to serum total alkaline phosphatase and serum bone Gla-protein.

Authors:  K Brixen; H K Nielsen; E F Eriksen; P Charles; L Mosekilde
Journal:  Calcif Tissue Int       Date:  1989-02       Impact factor: 4.333

4.  Linear decline in serum alkaline phosphatase activity during treatment of renal osteodystrophy.

Authors:  E J Will; M S Knapp; D McGivern
Journal:  Br Med J (Clin Res Ed)       Date:  1983-01-08

5.  Serum osteocalcin and bone isoenzyme alkaline phosphatase in growth hormone-deficient patients: dose-response studies with biosynthetic human GH.

Authors:  H K Nielsen; J O Jørgensen; K Brixen; J S Christiansen
Journal:  Calcif Tissue Int       Date:  1991-02       Impact factor: 4.333

6.  Glucocorticoid therapy causes contradictory changes of serum Wnt signaling-related molecules in systemic autoimmune diseases.

Authors:  Mai Kawazoe; Kaichi Kaneko; Kotaro Shikano; Natsuko Kusunoki; Toshihiro Nanki; Shinichi Kawai
Journal:  Clin Rheumatol       Date:  2017-05-27       Impact factor: 2.980

7.  Enhancement of drug delivery to bone: characterization of human tissue-nonspecific alkaline phosphatase tagged with an acidic oligopeptide.

Authors:  Tatsuo Nishioka; Shunji Tomatsu; Monica A Gutierrez; Ken-ichi Miyamoto; Georgeta G Trandafirescu; Patricia L C Lopez; Jeffrey H Grubb; Rie Kanai; Hironori Kobayashi; Seiji Yamaguchi; Gary S Gottesman; Richard Cahill; Akihiko Noguchi; William S Sly
Journal:  Mol Genet Metab       Date:  2006-04-17       Impact factor: 4.797

8.  Short-term effects of glucocorticoid therapy on biochemical markers of bone metabolism in Japanese patients: a prospective study.

Authors:  Yasuo Kuroki; Hiroshi Kaji; Seiji Kawano; Fumio Kanda; Yutaka Takai; Michiko Kajikawa; Toshitsugu Sugimoto
Journal:  J Bone Miner Metab       Date:  2008-05-11       Impact factor: 2.626

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.